Drug Shortage Report for VANTAS
| Report ID | 4358 |
| Drug Identification Number | 02278383 |
| Brand name | VANTAS |
| Common or Proper name | HISTRELIN ACETATE |
| Company Name | PALADIN LABS INC. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | HISTRELIN ACETATE |
| Strength(s) | 50MG |
| Dosage form(s) | IMPLANT KIT |
| Route of administration | SUBCUTANEOUS |
| Packaging size | 1 vial |
| ATC code | L02AE |
| ATC description | HORMONES AND RELATED AGENTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2006-07-15 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2020-06-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 SAINT-LAURENT, QUEBEC CANADA H4M 2P2 |
| Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2017-03-27 | English | Compare |
| v2 | 2017-03-27 | French | Compare |
Showing 1 to 2 of 2